The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC
By
COR2ED The Heart of Medical Education
FEATURING
Umberto Malapelle
By
COR2ED The Heart of Medical Education
FEATURING
Umberto Malapelle
How is the role of liquid biopsy changing biomarker testing in solid tumours? Which biomarkers can be tested and when should it be optimally used?
In this clinical topic newsletter, you’ll hear pathologist Assoc. Prof. Umberto Malapelle share his insights into:
- Exactly how the role of liquid biopsy is evolving in precision oncology
- The clinical application of liquid biopsies across the cancer patient journey
- How this applies to non-small cell lung cancer (NSCLC), breast cancer, and colorectal cancer.
Clinical takeaways from the video include:
- Liquid biopsies offer a less invasive alternative to traditional tissue biopsies in patients with solid tumours, to examine molecular features
- The role of liquid biopsy should be seen as a complementary testing method to tissue-based assays and the information derived should be reviewed in combination with tissue results
- The clinical application of liquid biopsies ranges from screening and diagnosis, treatment guidance, monitoring minimal residual disease to assessing chemotherapy resistance.
To view and/or download the accompanying slides to this video, go to the Cor2ed website
Follow us on social media:
X
LinkedIn
This content is intended for healthcare professionals only. The medical expert in this video is expressing their own views and not those of COR2ED, Supporters or their institution. This podcast is supported by an Independent Medical Education Grant from Bayer.
This video was developed by cor2ed.com and published in July 2024.
In this clinical topic newsletter, you’ll hear pathologist Assoc. Prof. Umberto Malapelle share his insights into:
- Exactly how the role of liquid biopsy is evolving in precision oncology
- The clinical application of liquid biopsies across the cancer patient journey
- How this applies to non-small cell lung cancer (NSCLC), breast cancer, and colorectal cancer.
Clinical takeaways from the video include:
- Liquid biopsies offer a less invasive alternative to traditional tissue biopsies in patients with solid tumours, to examine molecular features
- The role of liquid biopsy should be seen as a complementary testing method to tissue-based assays and the information derived should be reviewed in combination with tissue results
- The clinical application of liquid biopsies ranges from screening and diagnosis, treatment guidance, monitoring minimal residual disease to assessing chemotherapy resistance.
To view and/or download the accompanying slides to this video, go to the Cor2ed website
Follow us on social media:
X
This content is intended for healthcare professionals only. The medical expert in this video is expressing their own views and not those of COR2ED, Supporters or their institution. This podcast is supported by an Independent Medical Education Grant from Bayer.
This video was developed by cor2ed.com and published in July 2024.
Comments 0
Login to view comments.
Click here to Login
